Improved pharmacovigilance signal detection using Bayesian generalized linear mixed models
From MaRDI portal
Cites work
- A likelihood ratio test based method for signal detection with application to FDA's drug safety data
- Accounting for Multiplicities in Assessing Drug Safety: A Three-Level Hierarchical Mixture Model
- Bayesian generalized linear low rank regression models for the detection of vaccine-adverse event associations
- Bayesian generalized low rank regression models for neuroimaging phenotypes and genetic markers
- Extended multi-item gamma Poisson shrinker methods based on the zero-inflated Poisson model for postmarket drug safety surveillance
- Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system
- Multivariate reduced-rank regression
- Optimal scaling for partially updating MCMC algorithms
- Reduced rank stochastic regression with a sparse singular value decomposition
- Sparse Bayesian infinite factor models
- Statistical analysis of factor models of high dimension
- The spike-and-slab LASSO
This page was built for publication: Improved pharmacovigilance signal detection using Bayesian generalized linear mixed models
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6907449)